How High Will Roku Stock Go?
Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…
Buy
56
STRM Quote, Financials, Valuation and Earnings
Last price:
$5.14
Seasonality move
:
12.53%
Day range:
$5.14 - $5.18
52-week range:
$1.82 - $9.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.16x
P/B ratio:
1.83x
Volume:
21.7K
Avg. volume:
133.9K
1-year change:
-33.99%
Market cap:
$22.4M
Revenue:
$17.9M
EPS (TTM):
-$2.41
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
STRM
Streamline Health Solutions
|
$5.3M | -- | -24.87% | -- | $22.50 |
|
CDT
Conduit Pharmaceuticals
|
-- | -- | -- | -- | -- |
|
LENZ
LENZ Therapeutics
|
-- | -$0.32 | -- | -26.67% | $44.50 |
|
LFMD
LifeMD
|
$62.5M | $0.14 | 30.87% | -93.33% | $12.83 |
|
MDRX
Veradigm
|
-- | -- | -- | -- | $8.17 |
|
TBRG
TruBridge
|
$86.2M | $0.29 | 2.3% | -28.23% | $29.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
STRM
Streamline Health Solutions
|
$5.18 | $22.50 | $22.4M | -- | $0.00 | 0% | 1.16x |
|
CDT
Conduit Pharmaceuticals
|
$2.33 | -- | $1.9M | -- | $0.00 | 0% | -- |
|
LENZ
LENZ Therapeutics
|
$29.00 | $44.50 | $816.2M | -- | $1.03 | 0% | -- |
|
LFMD
LifeMD
|
$12.46 | $12.83 | $566.3M | -- | $0.00 | 0% | 2.28x |
|
MDRX
Veradigm
|
$4.50 | $8.17 | $487.2M | -- | $0.00 | 0% | 0.95x |
|
TBRG
TruBridge
|
$23.77 | $29.25 | $357.1M | -- | $0.00 | 0% | 0.98x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
STRM
Streamline Health Solutions
|
46.84% | 4.707 | 128.9% | 0.41x |
|
CDT
Conduit Pharmaceuticals
|
-- | 0.069 | -- | -- |
|
LENZ
LENZ Therapeutics
|
-- | 0.835 | -- | -- |
|
LFMD
LifeMD
|
114.46% | 4.827 | 8.05% | 0.73x |
|
MDRX
Veradigm
|
-- | 0.994 | -- | -- |
|
TBRG
TruBridge
|
49.9% | 1.309 | 40.59% | 1.34x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
STRM
Streamline Health Solutions
|
$2M | -$2M | -32.78% | -54.79% | -44.81% | -$2M |
|
CDT
Conduit Pharmaceuticals
|
-- | -$4M | -- | -- | -- | -$4.3M |
|
LENZ
LENZ Therapeutics
|
-- | -$16.9M | -- | -- | -- | -$16.2M |
|
LFMD
LifeMD
|
$57.1M | $2.5M | -66.95% | -- | 3.87% | $201K |
|
MDRX
Veradigm
|
-- | -- | -- | -- | -- | -- |
|
TBRG
TruBridge
|
$47.7M | $8.2M | -4.97% | -9.97% | 9.52% | $1.4M |
Streamline Health Solutions vs. Competitors
-
Which has Higher Returns STRM or CDT?
Conduit Pharmaceuticals has a net margin of -56.03% compared to Streamline Health Solutions's net margin of --. Streamline Health Solutions's return on equity of -54.79% beat Conduit Pharmaceuticals's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital STRMStreamline Health Solutions46.03% -$0.61 $26.2M CDTConduit Pharmaceuticals-- -$19.80 -- -
What do Analysts Say About STRM or CDT?
Streamline Health Solutions has a consensus price target of $22.50, signalling downside risk potential of -71.02%. On the other hand Conduit Pharmaceuticals has an analysts' consensus of -- which suggests that it could fall by --. Given that Streamline Health Solutions has higher upside potential than Conduit Pharmaceuticals, analysts believe Streamline Health Solutions is more attractive than Conduit Pharmaceuticals.
Company Buy Ratings Hold Ratings Sell Ratings STRMStreamline Health Solutions1 0 0 CDTConduit Pharmaceuticals0 0 0 -
Is STRM or CDT More Risky?
Streamline Health Solutions has a beta of 2.060, which suggesting that the stock is 105.994% more volatile than S&P 500. In comparison Conduit Pharmaceuticals has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock STRM or CDT?
Streamline Health Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Conduit Pharmaceuticals offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Streamline Health Solutions pays -- of its earnings as a dividend. Conduit Pharmaceuticals pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STRM or CDT?
Streamline Health Solutions quarterly revenues are $4.4M, which are larger than Conduit Pharmaceuticals quarterly revenues of --. Streamline Health Solutions's net income of -$2.5M is higher than Conduit Pharmaceuticals's net income of -$5.1M. Notably, Streamline Health Solutions's price-to-earnings ratio is -- while Conduit Pharmaceuticals's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Streamline Health Solutions is 1.16x versus -- for Conduit Pharmaceuticals. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STRMStreamline Health Solutions1.16x -- $4.4M -$2.5M CDTConduit Pharmaceuticals-- -- -- -$5.1M
-
Which has Higher Returns STRM or LENZ?
LENZ Therapeutics has a net margin of -56.03% compared to Streamline Health Solutions's net margin of --. Streamline Health Solutions's return on equity of -54.79% beat LENZ Therapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital STRMStreamline Health Solutions46.03% -$0.61 $26.2M LENZLENZ Therapeutics-- -$0.53 -- -
What do Analysts Say About STRM or LENZ?
Streamline Health Solutions has a consensus price target of $22.50, signalling downside risk potential of -71.02%. On the other hand LENZ Therapeutics has an analysts' consensus of $44.50 which suggests that it could grow by 53.45%. Given that LENZ Therapeutics has higher upside potential than Streamline Health Solutions, analysts believe LENZ Therapeutics is more attractive than Streamline Health Solutions.
Company Buy Ratings Hold Ratings Sell Ratings STRMStreamline Health Solutions1 0 0 LENZLENZ Therapeutics5 0 0 -
Is STRM or LENZ More Risky?
Streamline Health Solutions has a beta of 2.060, which suggesting that the stock is 105.994% more volatile than S&P 500. In comparison LENZ Therapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock STRM or LENZ?
Streamline Health Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENZ Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $1.03 per share. Streamline Health Solutions pays -- of its earnings as a dividend. LENZ Therapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STRM or LENZ?
Streamline Health Solutions quarterly revenues are $4.4M, which are larger than LENZ Therapeutics quarterly revenues of --. Streamline Health Solutions's net income of -$2.5M is higher than LENZ Therapeutics's net income of -$14.6M. Notably, Streamline Health Solutions's price-to-earnings ratio is -- while LENZ Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Streamline Health Solutions is 1.16x versus -- for LENZ Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STRMStreamline Health Solutions1.16x -- $4.4M -$2.5M LENZLENZ Therapeutics-- -- -- -$14.6M
-
Which has Higher Returns STRM or LFMD?
LifeMD has a net margin of -56.03% compared to Streamline Health Solutions's net margin of 2.11%. Streamline Health Solutions's return on equity of -54.79% beat LifeMD's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital STRMStreamline Health Solutions46.03% -$0.61 $26.2M LFMDLifeMD86.84% $0.01 $18M -
What do Analysts Say About STRM or LFMD?
Streamline Health Solutions has a consensus price target of $22.50, signalling downside risk potential of -71.02%. On the other hand LifeMD has an analysts' consensus of $12.83 which suggests that it could grow by 3%. Given that LifeMD has higher upside potential than Streamline Health Solutions, analysts believe LifeMD is more attractive than Streamline Health Solutions.
Company Buy Ratings Hold Ratings Sell Ratings STRMStreamline Health Solutions1 0 0 LFMDLifeMD5 1 0 -
Is STRM or LFMD More Risky?
Streamline Health Solutions has a beta of 2.060, which suggesting that the stock is 105.994% more volatile than S&P 500. In comparison LifeMD has a beta of 2.423, suggesting its more volatile than the S&P 500 by 142.276%.
-
Which is a Better Dividend Stock STRM or LFMD?
Streamline Health Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeMD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Streamline Health Solutions pays -- of its earnings as a dividend. LifeMD pays out -16.45% of its earnings as a dividend.
-
Which has Better Financial Ratios STRM or LFMD?
Streamline Health Solutions quarterly revenues are $4.4M, which are smaller than LifeMD quarterly revenues of $65.7M. Streamline Health Solutions's net income of -$2.5M is lower than LifeMD's net income of $1.4M. Notably, Streamline Health Solutions's price-to-earnings ratio is -- while LifeMD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Streamline Health Solutions is 1.16x versus 2.28x for LifeMD. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STRMStreamline Health Solutions1.16x -- $4.4M -$2.5M LFMDLifeMD2.28x -- $65.7M $1.4M
-
Which has Higher Returns STRM or MDRX?
Veradigm has a net margin of -56.03% compared to Streamline Health Solutions's net margin of --. Streamline Health Solutions's return on equity of -54.79% beat Veradigm's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital STRMStreamline Health Solutions46.03% -$0.61 $26.2M MDRXVeradigm-- -- -- -
What do Analysts Say About STRM or MDRX?
Streamline Health Solutions has a consensus price target of $22.50, signalling downside risk potential of -71.02%. On the other hand Veradigm has an analysts' consensus of $8.17 which suggests that it could grow by 81.48%. Given that Veradigm has higher upside potential than Streamline Health Solutions, analysts believe Veradigm is more attractive than Streamline Health Solutions.
Company Buy Ratings Hold Ratings Sell Ratings STRMStreamline Health Solutions1 0 0 MDRXVeradigm1 2 0 -
Is STRM or MDRX More Risky?
Streamline Health Solutions has a beta of 2.060, which suggesting that the stock is 105.994% more volatile than S&P 500. In comparison Veradigm has a beta of 0.768, suggesting its less volatile than the S&P 500 by 23.191%.
-
Which is a Better Dividend Stock STRM or MDRX?
Streamline Health Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veradigm offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Streamline Health Solutions pays -- of its earnings as a dividend. Veradigm pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STRM or MDRX?
Streamline Health Solutions quarterly revenues are $4.4M, which are larger than Veradigm quarterly revenues of --. Streamline Health Solutions's net income of -$2.5M is higher than Veradigm's net income of --. Notably, Streamline Health Solutions's price-to-earnings ratio is -- while Veradigm's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Streamline Health Solutions is 1.16x versus 0.95x for Veradigm. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STRMStreamline Health Solutions1.16x -- $4.4M -$2.5M MDRXVeradigm0.95x -- -- --
-
Which has Higher Returns STRM or TBRG?
TruBridge has a net margin of -56.03% compared to Streamline Health Solutions's net margin of 0.53%. Streamline Health Solutions's return on equity of -54.79% beat TruBridge's return on equity of -9.97%.
Company Gross Margin Earnings Per Share Invested Capital STRMStreamline Health Solutions46.03% -$0.61 $26.2M TBRGTruBridge54.69% $0.03 $336.3M -
What do Analysts Say About STRM or TBRG?
Streamline Health Solutions has a consensus price target of $22.50, signalling downside risk potential of -71.02%. On the other hand TruBridge has an analysts' consensus of $29.25 which suggests that it could grow by 23.05%. Given that TruBridge has higher upside potential than Streamline Health Solutions, analysts believe TruBridge is more attractive than Streamline Health Solutions.
Company Buy Ratings Hold Ratings Sell Ratings STRMStreamline Health Solutions1 0 0 TBRGTruBridge2 2 0 -
Is STRM or TBRG More Risky?
Streamline Health Solutions has a beta of 2.060, which suggesting that the stock is 105.994% more volatile than S&P 500. In comparison TruBridge has a beta of 0.632, suggesting its less volatile than the S&P 500 by 36.828%.
-
Which is a Better Dividend Stock STRM or TBRG?
Streamline Health Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TruBridge offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Streamline Health Solutions pays -- of its earnings as a dividend. TruBridge pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STRM or TBRG?
Streamline Health Solutions quarterly revenues are $4.4M, which are smaller than TruBridge quarterly revenues of $87.2M. Streamline Health Solutions's net income of -$2.5M is lower than TruBridge's net income of $459K. Notably, Streamline Health Solutions's price-to-earnings ratio is -- while TruBridge's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Streamline Health Solutions is 1.16x versus 0.98x for TruBridge. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STRMStreamline Health Solutions1.16x -- $4.4M -$2.5M TBRGTruBridge0.98x -- $87.2M $459K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will The Trade Desk’s Stock Be in 5 Years?
If you stitched together every advertisement The Trade Desk (NASDAQ:…
Is MSTR Stock Fundamentally Misunderstood?
Software firm turned Bitcoin treasury Strategy (NASDAQ:MSTR) has made waves…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
74
DAVE alert for Jun 14
Dave [DAVE] is down 12.68% over the past day.
Buy
54
DAR alert for Jun 14
Darling Ingredients [DAR] is up 9.12% over the past day.
Sell
9
NAIL alert for Jun 14
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is down 8.8% over the past day.
